As of 2026-03-29, the Relative Valuation of Puma Biotechnology Inc (PBYI) is 14.46 USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.08 USD, the upside of Puma Biotechnology Inc based on Relative Valuation is 137.9%.
The range of the Relative Valuation is 13.27 - 16.17 USD.
| Range | Selected | |
| Trailing P/E multiples | 22.3x - 26.4x | 24.4x |
| Forward P/E multiples | 20.8x - 24.9x | 21.9x |
| Fair Price | 13.27 - 16.17 | 14.46 |
| Upside | 118.3% - 165.9% | 137.9% |
| Date | P/E |
| 2026-03-20 | 10.01 |
| 2026-03-19 | 10.06 |
| 2026-03-18 | 9.81 |
| 2026-03-17 | 10.04 |
| 2026-03-16 | 9.93 |
| 2026-03-13 | 9.65 |
| 2026-03-12 | 9.62 |
| 2026-03-11 | 9.81 |
| 2026-03-10 | 9.91 |
| 2026-03-09 | 10.17 |
| 2026-03-06 | 9.89 |
| 2026-03-05 | 10.19 |
| 2026-03-04 | 10.47 |
| 2026-03-03 | 10.16 |
| 2026-03-02 | 10.50 |
| 2026-02-27 | 9.32 |
| 2026-02-26 | 12.43 |
| 2026-02-25 | 12.56 |
| 2026-02-24 | 12.25 |
| 2026-02-23 | 11.63 |
| 2026-02-20 | 11.17 |
| 2026-02-19 | 11.10 |
| 2026-02-18 | 10.92 |
| 2026-02-17 | 11.04 |
| 2026-02-13 | 11.15 |
| 2026-02-12 | 11.12 |
| 2026-02-11 | 10.86 |
| 2026-02-10 | 10.81 |
| 2026-02-09 | 11.25 |
| 2026-02-06 | 11.35 |
| 2026-02-05 | 11.10 |
| 2026-02-04 | 11.61 |
| 2026-02-03 | 11.61 |
| 2026-02-02 | 11.15 |
| 2026-01-30 | 10.60 |
| 2026-01-29 | 10.52 |
| 2026-01-28 | 10.34 |
| 2026-01-27 | 10.74 |
| 2026-01-26 | 10.52 |
| 2026-01-23 | 10.50 |
| 2026-01-22 | 11.22 |
| 2026-01-21 | 11.27 |
| 2026-01-20 | 10.79 |
| 2026-01-16 | 10.42 |
| 2026-01-15 | 10.43 |
| 2026-01-14 | 10.50 |
| 2026-01-13 | 10.21 |
| 2026-01-12 | 10.27 |
| 2026-01-09 | 9.99 |
| 2026-01-08 | 10.14 |